Shyam Bishen, Ph.D., MS, MBA

The life sciences sector is revolutionizing healthcare globally, and Saudi Arabia is at the forefront of this transformation. With Vision 2030 and the national biotech strategy, the Kingdom aims to establish itself as a global biotech hub by 2040, driving economic growth, innovation, and improved healthcare outcomes. It's an exciting time for the biotechnology sector, filled with unprecedented opportunities and advancements. a Check out my latest article on how we can collaboratively shape the future by advancing life sciences in Saudi Arabia. #LifeSciences #HealthcareInnovation #Vision2030 #SaudiArabia https://lnkd.in/dMr2gx-N

124

3 Comments

The #PHSSR 3rd Summit was a significant event held during Abu Dhabi Global Healthcare Week, bringing together health system policymakers, experts, and stakeholders worldwide to discuss and enhance global health systems. Key highlights include: 1 - Opening addresses by @AstraZeneca's Chair Michel Demaré and prominent health leaders from Abu Dhabi, Egypt, and Greece. 2 - Launch of the Abu Dhabi PHSSR report with essential policy recommendations on non-communicable diseases and the climate-health nexus. Check out the wrap-up video to learn more about our collective efforts to build resilient health systems. #ADGHW #HealthSystems #GlobalHealth

102

1 Comment

Do you know the pharmaco-economics requirements in these countries: Algeria, Egypt, Iraq, Jordan, Saudi Arabia, Lebanon, Morocco, Tunisia, and the UAE? Check them out in this article. #pharmacoeconomics #MENA #MarketAccess Market Access Today

3

The #PHSSR 3rd Summit was a significant event held during Abu Dhabi Global Healthcare Week, bringing together health system policymakers, experts, and stakeholders worldwide to discuss and enhance global health systems. Key highlights include: - Opening addresses by @AstraZeneca's Chair Michel Demaré and prominent health leaders from Abu Dhabi, Egypt, and Greece. - Launch of the Abu Dhabi PHSSR report with essential policy recommendations on non-communicable diseases and the climate-health nexus. Check out the wrap-up video to learn more about our collective efforts to build resilient health systems. #ADGHW #HealthSystems #GlobalHealth

16

2 Comments

I feel proud to be at Abbott - amongst World’s Top 10 Leading Pharma Giant Here are some of the quick facts which you must know: 1. Abbott's products reach over 160 countries, impacting the lives of millions worldwide. 2. Every day, over 1.5 million people rely on Abbott's life-saving medicines and medical devices. 3. Abbott's diagnostics division conducts over 500 million tests annually, aiding in early disease detection and management. 4. Abbott's nutrition products serve over 200 million people globally, providing essential nutrients for optimal health. 5. Abbott invests over $1.5 billion (₹150 Crores) annually in research and development, driving innovation in healthcare solutions. 6. Abbott's pharmaceuticals division has a portfolio of over 30 marketed drugs, addressing a wide range of therapeutic areas, from chronic diseases to rare disorders. 7. Abbott's medical devices division manufactures over 29 million diabetes care products annually, helping individuals manage their condition effectively. 8. Abbott's commitment to sustainability includes reducing its environmental footprint by achieving carbon neutrality in its operations and sourcing renewable energy for its facilities. With such scale and impact, Abbott is at the forefront of building a healthier world for generations to come. #HealthcareInnovation #GlobalImpact #MedTechLeadership #PharmaExcellence #PublicHealthHeroes #IndustryPartnerships #BuildingABetterFuture #HealthcareLeaders #CreatingOpportunities #FutureOfWork

347

2 Comments

The MENA region holds great potential for medical advancements, yet it remains underrepresented in global clinical research. Increasing the number of clinical trials is crucial for ensuring effective and safe treatments for diverse populations. We are committed to addressing this gap through regulatory harmonization, infrastructure development, capacity building, public awareness, and collaborative networks. By focusing on these key areas, we aim to create a more inclusive global health research landscape. Together, we can unlock the region's potential for groundbreaking medical innovations. #ClinicalTrials #MENARegion #HealthResearch #GlobalHealth

3

Reflecting on last year's PharmaVoice 100, it's remarkable how our strongest leaders have upheld the industry amid global upheaval. 🌐💼 Our #PharmaVoice100 champions remind us of the enduring pillars that uphold our sector. From cutting-edge #science to unwavering entrepreneurship, it's their drive that keeps our mission alive - delivering exceptional clinical outcomes for those in need. 🧬💡 Yet, the road ahead is speckled with challenges. Drug pricing debates continue to stir the pot while health disparities persist. Despite these, our leaders exemplify resilience; they're not just meeting expectations, they're redefining them. Innovating. Accessing. Including. Mentoring. 🌟 Our list echoes the legacy of pharmaceuticals while spotlighting the new foundations being laid. Amidst a realm of cancer conquerors and rare disease defenders, we see tech titans and masterful marketers making their mark. 💻✨ So, here's to the leaders past, present, and those emerging. It's an industry that never stops caring, evolving, or inspiring. Join us in celebrating them - and maybe, cast a vote for the next generation of PharmaVoice 100 before May 5th. 🏆👥 #Innovation #Leadership #HealthTech [Voting Link](https://lnkd.in/eJNHBDah) [PharmaVoice 100 2023] (https://lnkd.in/eXbK6pK9)

2

#AI can help us deliver healthcare in a world with too few doctors, according to ZS CEO Pratap Khedkar and Principal Ahmed Albaiti. Find out the shifts the industry will need to make—and why the authors are optimistic about a future of healthcare abundance. https://lnkd.in/euCuqhsB

7

Reflecting on the first half of 2024, it's clear that a mix of strategic necessity and opportunistic innovation has driven increased M&A activity within the pharma and life sciences sector. Elevated interest rates, regulatory pressures and an impending patent cliff have created a dynamic, highly competitive environment. Companies must be more strategic than ever in pursuing promising innovative assets to fill their pipelines. Looking ahead to the second half of 2024, I suspect we will continue to see strategic M&A as a key driver of transformation, perhaps at a slower pace. With high interest rates demanding higher returns, well-prepared sellers with robust data will attract the most interest. Additionally, I wonder how many companies are utilising new tools, like AI, to help them make de-risked decisions at a faster pace when they consider acquiring new assets. One thing for sure is that the industry continues to be anything but dull. With challenges bringing new ways of thinking and doing things, I'm excited to see how these dynamics play out and how we, as an industry, can leverage these opportunities to drive meaningful advancements in healthcare. https://lnkd.in/dZRdaap9

24

🚀 Unlocking the Value: Quantifying the Return on Investment of Hospital Artificial Intelligence Thrilled to share that our paper in #JACR, “Unlocking the Value: Quantifying the Return on Investment of Hospital Artificial Intelligence,” was published in March! Though a bit late with the news, my excitement hasn’t waned. We've developed a comprehensive #ROI calculator to evaluate the monetary and nonmonetary benefits of an AI-powered radiology diagnostic imaging platform—crucial for #AI adoption in #healthcare, particulairly in #Radiology. Public funding in this area is scarce, and radiologists need to know where they get the biggest bang for their buck. I hope this brings us closer to ending the dilemma of “without funding no evidence, but without evidence no funding.” This publication goes beyond typical marketing approaches you may know from other companies. Not only is it peer-reviewed, but as a pharmaceutical company, health economic modelling is in our DNA. 😉 🔗 Read the full publication here: https://lnkd.in/einAjbiC A huge thanks to my esteemed co-authors: Lauren Nicola, Prateek Bharadwaj, Michael Blankenburg, Dr. rer. nat., MBA, MPH, Petar A., Neda Tanova, Federica Sensini and Manon Breau-Brunel. Key Outcomes of our Model: 💰 451% ROI over five years (without time saving) through additional downstream procedures or efficiencies in the patient pathway (reduction of hospital lengths of stay, increase in follow-up scans and procedures, etc.) 💰⏱  791% ROI when accounting for time savings: Significant time savings for standalone hospitals include 15+ days of waiting time, 78 days in triage time, 10 days in reading time, and 41 days in reporting time. 💻    Synergies in IT operations: Accelerated access to innovation and convenience (single point of contact) for users. Key Principles 💰⏱ Multidimensionality: Evaluating both financial and non-financial benefits across the full patient journey for different stakeholders. Time saving does not necessarily mean cost saving or revenue generation. ⚙      Customization: Adapting inputs based on organizational needs. Each radiology unit has unique workflow challenges. 🔍      Data-driven: Sourcing inputs from thorough literature research and expert reviews, not marketing wishes. #HealthcareAI #HealthEconomics #ValueBasedCare #AIinHealthcare #Innovation #teamBayer #Calantic

46

Healthtech is a hot sector for venture capitalists and investors. However, the influx of similar solutions and changing regulations pose challenges. There could be value in contrarian investing - going against the hype, such as short selling overvalued healthtech stocks or supporting traditional healthcare firms. But this involves deep research and trend-spotting.

3

1 Comment

📌 MANAGEMENT PILLS 📌 “𝘔𝘦𝘢𝘴𝘶𝘳𝘦 𝘸𝘩𝘢𝘵 𝘪𝘴 𝘮𝘦𝘢𝘴𝘶𝘳𝘢𝘣𝘭𝘦, 𝘢𝘯𝘥 𝘮𝘢𝘬𝘦 𝘮𝘦𝘢𝘴𝘶𝘳𝘢𝘣𝘭𝘦 𝘸𝘩𝘢𝘵 𝘪𝘴 𝘯𝘰𝘵 𝘴𝘰.” - Galileo Galilei 🔍 The Importance of Measurement in Management Measuring performance and correlating numbers is essential for understanding your business’s current state. Accurate measurement helps identify critical points, enabling targeted action plans that drive sustainable transformation. 📈 Why It Matters 1. Clarity and Insight: Provides a clear picture of where your organization stands. 2. Identifying Weaknesses: Pinpoints areas needing improvement. 3. Informed Decisions: Enables effective decision-making. 4. Sustainable Growth: Lays a foundation for long-term success. 🛠️ Steps to Effective Measurement and Analysis 1. Define KPIs: • Identify relevant, clear, and actionable KPIs. 2. Gather Data: • Collect accurate data from reliable sources. 3. Analyze Data: • Identify trends and patterns using statistical methods. 4. Identify Critical Points: • Focus on areas with significant discrepancies. 5. Develop Action Plans: • Create specific, achievable, and time-bound plans. 6. Collaborate and Communicate: • Involve stakeholders and maintain transparent communication. 7. Implement and Monitor: • Execute plans and continuously monitor progress. 8. Review and Refine: • Regularly review performance data and adjust strategies. 💡 Tips • Use Technology: Enhance analysis with advanced tools. • Foster a Data-Driven Culture: Encourage data use in daily operations. • Benchmarking: Compare performance against industry standards. ❌ Common Pitfalls to Avoid • Ignoring Data: Leads to missed opportunities. • Overcomplicating KPIs: Focus on impactful metrics. • Lack of Follow-Through: Ensure proper implementation and monitoring. By committing to accurate measurement and continuous improvement, you can rebuild your business foundation for superior performance across all indicators.

29

1 Comment

#GenAI is fading lines between #Marketing and #Sales As Gen AI takes over the transactional aspects, the traditional divide between marketing and sales may completely dissolve in next 1-3 years, imo. AI-driven personalized engagements will encompass both building awareness and closing the deal. Broadcast marketing (e.g. for Superbowl Ads) may persist to establish brand trust, but the core focus shifts to individual AI-to-AI negotiations. Infinite labor, infinite content, infinite interactivity, and more ..... great read! https://lnkd.in/dHaeE8gP

4

** Breaking! ** #PUBLICHEALTH #HEALTHCARE The World Health Assembly (WHA) reached what it describes as an ‘historic’ agreement on revisions to the International Health Regulations (IHR), but a Pandemic Agreement proved out of reach. “The world made history at the World Health Assembly negotiations. After two years of negotiations, it has adopted a strong package of amendments based on the lessons learnt from the COVID-19 pandemic,” Dr. Tedros Adhanom Ghebreyesus, World Health Organisation Director-General, said on Saturday (1 June). * PILLAR 1: ONE BILLION MORE PEOPLE BENEFITING FROM UNIVERSAL HEALTH COVERAGE * PILLAR 2: ONE BILLION MORE PEOPLE BETTER PROTECTED FROM HEALTH EMERGENCIES * PILLAR 3: ONE BILLION MORE PEOPLE ENJOYING BETTER HEALTH AND WELL-BEING * PILLAR 4: MORE EFFECTIVE AND EFFICIENT WHO PROVIDING BETTER SUPPORT TO COUNTRIES

1

Number of Newly Funded AI Startups Between 2013-2023 This graphic shows the top 15 countries by their number of newly funded AI companies over the past decade (2013 to 2023). Figures come from Quid, accessed via Stanford University’s 2024 Artificial Intelligence Index Report. Note: This dataset only includes startups that received over $1.5M in private investment. America’s entrepreneurial spirit is evident here, with the U.S. funding more AI startups than all of the other countries on this list. In terms of capital, American AI startups raised an impressive $335B in private investment between 2013 and 2023, which is again significantly more than other countries. Chinese AI companies raised $104B over the same timeframe, while UK firms raised $22B. Source: https://lnkd.in/eKMDe2H6 #ai #artificialintelligence #aistartups

2

1 Comment

Some headline thoughts on current transformational focus for #pharma from the opening panel with Ronízia Moura, Saskia Steinacker and Mostafa Taha at NEXT Pharma Summit … New skills around tech and AI are needed (both upskilling internally and bringing in new talent), there is a need to combine agility (which happens locally or in smaller groups) with global scalability, it’s critical to break down silos and ensure everyone is innovating in the same direction….and senior leadership understanding and support is more critical than ever (and still not universally there across all companies).

26

2 Comments

Tomorrow marks the beginning of the Partnership for Health System Sustainability and Resilience (PHSSR) 3rd Summit at Abu Dhabi National Exhibition Centre to foster insightful discussions on innovation and resilience in health systems. At this summit, @AstraZeneca will address the critical need for health systems to adapt in response to a variety of challenges in our region, including workforce shortages, the rising prevalence of non-communicable diseases (#NCDs), and the increasing demands from aging populations, all compounded by economic pressures and climate-related disasters. These issues highlight the vulnerability of current health systems and emphasise the urgent need for transformative approaches. Our efforts to advance innovation are demonstrated through initiatives designed to equip health systems for today’s needs and future challenges. And it gives us great pride to have representatives from the #NearEast and #Maghreb, specifically from Morocco, Dr. Imane Kendili and Prof. Chekib Nejjari to give their views and participate in the discussions for better sustainable and resilient healthcare systems amidst climate change. The event is open to all attendees of Abu Dhabi Global Healthcare Week, and we eagerly anticipate your participation. We look forward to seeing you there! == #Sustainability #Resilience #Health #Partnerships #ADGHW #FutureOfHealthcare #GlobalHealthcare #AbuDhabiGlobalHealthcareWeek Rami Scandar Qutaiba Al Manaseer Jennifer Jackson Amine Sekhri Chakib Nejjari Imane Kendili Maria Nauss

21

1 Comment